ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,925Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 457

$492K Total Retail Price of All Prescriptions

Rank: 20 out of 457

489 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

2% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 7,632 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
METOPROLOL SUCCINATE 635 483 1 1
CRESTOR 497 416 2 14
AMLODIPINE BESYLATE 474 384 3 6
ATORVASTATIN CALCIUM 404 321 4 11
CARVEDILOL 388 286 5 2
RAMIPRIL 380 294 6 22
CLOPIDOGREL 352 293 7 10
SIMVASTATIN 338 245 8 7
LISINOPRIL 324 231 9 3
FUROSEMIDE 312 236 10 5
LOSARTAN POTASSIUM 301 231 11 16
METOPROLOL TARTRATE 242 199 12 4
PLAVIX 223 192 13 12
FAMOTIDINE 212 182 14 95
ISOSORBIDE MONONITRATE ER 208 183 15 9
OMEPRAZOLE 206 153 16 25
LEVOTHYROXINE SODIUM 205 153 17 33
SPIRONOLACTONE 192 137 18 19
NITROGLYCERIN PATCH 185 168 19 59
AMIODARONE HCL 184 160 20 24
METFORMIN HCL 152 101 21 42
PANTOPRAZOLE SODIUM 144 125 22 34
WARFARIN SODIUM 142 121 23 8
NITROSTAT 138 93 24 21
GLIMEPIRIDE 136 105 25 74
LIPITOR 123 95 26 47
BENICAR 110 85 27 102
ATENOLOL 104 66 28 17
POTASSIUM CHLORIDE 91 54 29 20
AZOR 79 59 30 129
KLOR-CON M20 77 63 31 35
LOSARTAN-HYDROCHLOROTHIAZIDE 76 72 32 39
ALLOPURINOL 67 57 33 52
ZOLPIDEM TARTRATE 63 32 34 51
BENAZEPRIL HCL 55 40 35 54
EFFIENT 55 43 35 48
TRAMADOL HCL 54 51 37 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.